tiprankstipranks
pc:helex

Helex

Helex is a therapeutics company developing a new class of targeted medicines for genetic kidney diseases using its proprietary LNP drug delivery and AI-based drug design platforms. The company aims to create disease-modifying therapies for chronic and rare kidney disorders, addressing significant unmet medical needs.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 30, 2025
Seed Round
$3.50M

Investors

Investor Name
Funding Round
Seed Round
Seed Round

Related News and Analysis